ALG Lung Cancer Registry (SAFRO2202)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

SAFRO2202 is a prospective, multicenter, non-interventional registry enrolling adults with confirmed lung cancer (NSCLC, SCLC, or carcinoid) who were diagnosed at inclusion or within the prior 12 months. The study runs across 21 public and university hospitals in Algeria and captures data during routine clinical care with no study-specific visits or interventions. Patient data are entered into a secure electronic case report form and include demographics, risk factors (notably smoking), tumor histology, staging, molecular markers (for example EGFR, ALK, PD-L1, KRAS, ROS1), treatments, and outcomes including treatment-related side effects. The registry plans to enroll about 1,500 patients per year over a 30-month period to generate real-world national-level evidence on lung cancer management and outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Histologically confirmed diagnosis of lung cancer (NSCLC, SCLC, or carcinoid tumor)
* Diagnosed at the time of inclusion or within the 12 previous months
* Fully managed (diagnosis, treatment, and follow-up) in an oncology or pulmonology department of one of the 21 participating public/university hospitals
* Signed informed consent obtained

Exclusion Criteria:

* Prior enrollment in this study
* Participation in an interventional clinical trial

Where it's running

• Centre Pierre et Marie Curie
  Algiers, Algiers Province, Algeria Recruiting
• Chu Beni Messous - Isaad Hassani
  Algiers, Algiers Province, Algeria Recruiting
• CHU Mohamed Lamine Debaghine - Bab-el-Oued
  Algiers, Algiers Province, Algeria Recruiting
• Chu-Beni Messous - Isaad Hassani
  Algiers, Algiers Province, Algeria Recruiting
• EPH Rouiba
  Algiers, Algiers Province, Algeria Recruiting
• CLCC Annaba
  Annaba, Annaba, Algeria Recruiting

Study contacts

• Principal investigator: Adda BOUNEDJAR, Professor of Medical Oncology — Frantz Fanon University Hospital, Cancer Center (CAC), Blida, Algeria
• Study coordinator: Louisa ISSIAKHEM LOUNICI, CEO
• Email: l.issiakhem@cmsolutionsdz.com
• Phone: +213 770 48 43 36

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multidisciplinary treatment planning for older people with lung cancer

  We will test a team-based approach that uses geriatric assessments to create personalized treatment plans for people aged 60–90 with newly diagnosed lung cancer to see if it improves 3-year progression-free survival compared with past patients.

  Recruiting West China Hospital · Chengdu, Sichuan · NCT07509333

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Telerehabilitation exercise program after lung cancer surgery

  A remote rehabilitation program with guided exercises is tested to help adults after lung cancer surgery recover better.

  Recruiting University of Seville · Seville, Andalusia · NCT07861282

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

  This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

  Recruiting Chest Diseases Hospital, Ministry of Health, Kuwait · Kuwait City · NCT07766538

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.